Case 1:20-cv-00393-LO-TCB Document 1296-1 Filed 06/08/22 Page 1 of 7 PageID# 33103
`Case 1:20-cv-00393-LO-TCB Document 1296-1 Filed 06/08/22 Page 1 of 7 PagelD# 33103
`
`
`
`
`
`
`
`
`
`
`EXHIBIT 1
`EXHIBIT 1
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`

`

`Case 1:20-cv-00393-LO-TCB Document 1296-1 Filed 06/08/22 Page 2 of 7 PageID# 33104
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE EASTERN DISTRICT OF VIRGINIA
`ALEXANDRIA DIVISION
`
`
`
`v.
`
`RAI STRATEGIC HOLDINGS, INC. and
`R.J. REYNOLDS VAPOR COMPANY,
`
`Plaintiffs and Counterclaim Defendants,
`
`
`
`ALTRIA CLIENT SERVICES LLC; PHILIP
`MORRIS USA INC.; and PHILIP MORRIS
`PRODUCTS S.A.,
`
`Defendants and Counterclaim Plaintiffs.
`
`Case No. 1:20-cv-00393-LO-TCB
`
`
`JOINT NOTICE OF ADDITIONAL AGREED MOTIONS IN LIMINE
`
`

`

`Case 1:20-cv-00393-LO-TCB Document 1296-1 Filed 06/08/22 Page 3 of 7 PageID# 33105
`
`All parties in this case stipulate to the following motions in limine. In addition to the agreed
`
`motions in limine 1-8 listed in Dkt. 822, all parties agree that they, their counsel, representatives,
`
`and all witnesses called by them (whether live or by deposition) will not mention, refer to,
`
`interrogate about, or attempt to convey to the jury in any manner, either directly or indirectly, any
`
`of the matters set forth below without obtaining a favorable ruling from this Court outside the
`
`presence of the jury. Should any party violate this stipulation, the parties agree that the Court
`
`should give they can seek a curative instruction from the Court to the jury to disregard the
`
`evidence; understanding that the parties retain their right to provided, however, that the other party
`
`reserves the right to move for any other additional relief, including but not limited to a mistrial as
`
`alternative relief if in its view a curative instruction would be insufficient to remove the prejudicial
`
`effect.
`
`9. Alleged
`class-based marketing of menthol products.
`race- and
`PMI/AltriaNeither party will not present argument, evidence, or testimony that
`Reynolds or any other company targets menthol products to any racial or class
`group. For example, Reynolds will not offer argument, evidence, or testimony that
`it did not market menthol products to or target African Americans with menthol
`products, and PMI/Altria will not in response interrogate any witness regarding
`such targeting or marketing.with questions like the ones asked by PMI/Altria’s
`counsel at the recent update 30(b)(6) deposition of Dr. James Figlar on June 3,
`2022:
`
` “Does Reynolds market menthol products to African-Americans?”
`
` “Has Reynolds ever been accused of targeting African-Americans with
`menthol tobacco products?”
`
` “Historically are you aware of any targeted marketing of menthol products
`to African-Americans by Reynolds?”
`10. Alleged youth marketing of menthol products. PMI/Altria Neither party will not
`present argument, evidence, or testimony that Reynolds or any other company
`targets menthol products to youth. For example, Reynolds will not offer argument,
`evidence, or testimony that it has not targeted youths with, or that it was unaware
`of youth use of, menthol or other non-tobacco flavored products, and PMI/Altria
`will not in response interrogate any witness regarding such targeting or
`
`
`
`-2-
`
`
`
`

`

`Case 1:20-cv-00393-LO-TCB Document 1296-1 Filed 06/08/22 Page 4 of 7 PageID# 33106
`
`marketing.with questions like the ones asked by PMI/Altria’s counsel at the recent
`update 30(b)(6) deposition of Dr. James Figlar on June 3, 2022:
`
` “[D]id Reynolds determine that youths are more likely to use menthol
`products than non-menthol products?”
`
` “Did Reynolds … reach any conclusions about … whether youth are more
`likely to use menthol than regular tobacco products?”
`11. Prospective FDA action regarding menthol or flavored tobacco products.
`PMI/AltriaNeither party will not present argument, evidence, or testimony
`connected to PMT authorization of menthol products, other than the undisputed fact
`that such PMT authorization requests remain pending with the FDA. For example,
`PMI/Altria will not interrogate any witness with questions like the ones asked by
`PMI/Altria’s counsel at the recent update 30(b)(6) deposition of Dr. James Figlar
`on June 3, 2022:
`
` “[W]hy the menthol flavors are still in review for the Vuse PMTAs”?
`
` “What’s your understanding of what the FDA’s concern is about menthol
`products”?
`12. Allegations made against Reynolds the Parties in product-liability cases.
`PMI/Altria Neither party will not present argument, evidence or testimony
`regarding the substance of the allegations made by plaintiffs in cigarette product
`liability cases. For instance, neither party will ask questions such asrelated to
`allegations against Reynolds in product-liability cases. For example, PMI/Altria
`will not interrogate any witness about these allegations with questions like the
`followingones asked by PMI/Altria’s counsel at the recent update 30(b)(6)
`deposition of Dr. James Figlar on June 3, 2022:
`
` “[W]hat were the allegations against Reynolds or Phillip Morris/Altria in
`those product liability cases?”
`
` “If you had to summarize for the jury in this case what the allegations were
`in the product liability cases that you testified in, what would you tell
`them?”
`13. Prior exclusion of expert testimony or opinion. Neither party will present
`argument, evidence, testimony, or suggestion related to the exclusion of any
`expert’s prior testimony or opinion in this case or any other case based on any
`court’s orders limiting the scope of testimony.
`
`
`
`
`
`-3-
`
`
`
`

`

`Case 1:20-cv-00393-LO-TCB Document 1296-1 Filed 06/08/22 Page 5 of 7 PageID# 33107
`
`
`
`/s/ David M. Maiorana
`David M. Maiorana (VA Bar No. 42334)
`Ryan B. McCrum
`JONES DAY
`901 Lakeside Avenue
`Cleveland, OH 44114
`Telephone: (216) 586-3939
`Facsimile: (216) 579-0212
`Email: dmaiorana@jonesday.com
`Email: rbmccrum@jonesday.com
`
`John J. Normile
`JONES DAY
`250 Vesey Street
`New York, NY 10281
`Tel: (212) 326-3939
`Fax: (212) 755-7306
`Email: jjnormile@jonesday.com
`
`Alexis A. Smith
`JONES DAY
`555 South Flower Street
`Fiftieth Floor
`Los Angeles, CA 90071
`Telephone: (213) 243-2653
`Facsimile: (213) 243-2539
`Email: asmith@jonesday.com
`
`Stephanie E. Parker
`JONES DAY
`1221 Peachtree Street, N.E.
`Suite 400
`Atlanta, GA 30361
`Telephone: (404) 521-3939
`Facsimile: (404) 581-8330
`Email: separker@jonesday.com
`
`Anthony M. Insogna
`JONES DAY
`4655 Executive Drive
`Suite 1500
`San Diego, CA 92121
`Telephone: (858) 314-1200
`Facsimile: (844) 345-3178
`Email: aminsogna@jonesday.com
`
`
`
`
`/s/ Maximilian A. Grant
`Maximilian A. Grant (VSB No. 91792)
`max.grant@lw.com
`Matthew J. Moore (pro hac vice)
`matthew.moore@lw.com
`LATHAM & WATKINS LLP
`555 Eleventh Street, N.W., Suite 1000
`Washington, DC 20004
`Telephone: (202) 637-2200
`Facsimile: (202) 637-2201
`
`Clement J. Naples (pro hac vice)
`clement.naples@lw.com
`LATHAM & WATKINS LLP
`885 Third Avenue
`New York, NY 10022-4834
`Tel: (212) 906-1200; Fax: (212) 751-4864
`
`Gregory J. Sobolski (pro hac vice)
`greg.sobolski@lw.com
`LATHAM & WATKINS LLP
`505 Montgomery Street, Suite 2000
`San Francisco, CA 94111
`Telephone: (415) 391-0600
`Facsimile: (415) 395-8095
`
`Brenda L. Danek (pro hac vice)
`brenda.danek@lw.com
`LATHAM & WATKINS LLP
`330 North Wabash Avenue, Suite 2800
`Chicago, IL 60611
`Tel: (312) 876-7700; Fax: (312) 993-9767
`
`Counsel for Defendants-Counterclaim
`Plaintiffs Altria Client Services LLC, Philip
`Morris USA Inc., and Philip Morris Products
`S.A.
`
`
`/s/ Elizabeth Stotland Weiswasser
`W. Sutton Ansley (VSB No. 80085)
`sutton.ansley@weil.com
`Robert T. Vlasis III (pro hac vice)
`robert.vlasis@weil.com
`Stephanie Adamakos (pro hac vice)
`stephanie.adamakos@weil.com
`WEIL, GOTSHAL & MANGES LLP
`
`
`
`
`
`-4-
`
`
`
`

`

`Case 1:20-cv-00393-LO-TCB Document 1296-1 Filed 06/08/22 Page 6 of 7 PageID# 33108
`
`William E. Devitt
`JONES DAY
`110 North Wacker Drive
`Suite 4800
`Chicago, IL 60606
`Telephone: (312) 269-4240
`Facsimile: (312) 782-8585
`Email: wdevitt@jonesday.com
`
`Sanjiv P. Laud
`JONES DAY
`90 South Seventh Street
`Suite 4950
`Minneapolis, MN 55402
`Telephone: (612) 217-8800
`Facsimile: (844) 345-3178
`Email: slaud@jonesday.com
`
`Charles B. Molster
`THE LAW OFFICES OF
`CHARLES B. MOLSTER, III PLLC
`2141 Wisconsin Avenue, N.W. Suite M
`Washington, DC 20007
`Telephone: (202) 787-1312
`Email: cmolster@molsterlaw.com
`
`Counsel for RAI Strategic Holdings, Inc. and
`R.J. Reynolds Vapor Company
`
`2001 M Street, NW, Suite 600
`Washington, DC 20036
`Tel: (202) 682-7000; Fax: 202-857-0940
`
`Elizabeth Stotland Weiswasser (pro hac vice)
`elizabeth.weiswasser@weil.com
`Anish R. Desai (pro hac vice)
`anish.desai@weil.com
`WEIL, GOTSHAL & MANGES LLP
`767 5th Avenue
`New York, NY 10153
`Tel: (212) 310-8000; Fax: 212-310-8007
`
`Adrian C. Percer (pro hac vice)
`adrian.percer@weil.com
`WEIL, GOTSHAL & MANGES LLP
`201 Redwood Shores Parkway
`Redwood Shores, CA 94065
`Tel: (650) 802-3000; Fax: 850-802-3100
`
`Counsel for Defendants-Counterclaim
`Plaintiffs Altria Client Services LLC and
`Philip Morris USA Inc.
`
`
`
`
`-5-
`
`
`
`

`

`Case 1:20-cv-00393-LO-TCB Document 1296-1 Filed 06/08/22 Page 7 of 7 PageID# 33109
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that on this 6th day of June, 2022, a true and correct copy of the foregoing
`
`was served using the Court’s CM/ECF system, with electronic notification of such filing to all
`
`counsel of record.
`
`
`
`
`
`
`
`
`
`
`
`
`
`/s/ David M. Maiorana
`David M. Maiorana (VA Bar No. 42334)
`JONES DAY
`901 Lakeside Ave.
`Cleveland, OH 44114
`Telephone: (216) 586-3939
`Facsimile: (216) 579-0212
`Email: dmaiorana@jonesday.com
`
`Counsel for RAI Strategic Holdings, Inc. and
`R.J. Reynolds Vapor Company
`
`
`
`
`
`